ORAMED PHARMACEUTICALS INC (ORMP) Institutional Ownership and Insiders Activity

ORAMED PHARMACEUTICALS INC (ORMP) is widely held by institutional investors, with 86 firms reporting positions valued at approximately $80.77M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Mercer Global Advisors Inc is the largest disclosed holder, reporting approximately $18.33M in ORMP holdings in its latest filing.

Recent insider activity includes 9 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.